Hexamethylmelamine treatment of sarcomas and lymphomas

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Oncogene·2012

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Oncogene·2011

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

British journal of cancer·2011

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

Oncogene·2007

Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.

Clinical pharmacology and therapeutics·2007

Malawi pilot study of Burkitt lymphoma treatment.

Medical and pediatric oncology·2003

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Medical and pediatric oncology·2003

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Medical and pediatric oncology·2003

Progress in Synthesis and Pharmacology of Telmisartan.

Chemistry & biodiversity·2026

Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.

Frontiers in psychiatry·2026

Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.

Frontiers in immunology·2026

Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond.

Cell biomaterials·2026

pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy.

Frontiers in immunology·2026

Related Experiment Videos

Hexamethylmelamine treatment of sarcomas and lymphomas

Related Concept Videos

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.

Malawi pilot study of Burkitt lymphoma treatment.

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Progress in Synthesis and Pharmacology of Telmisartan.

Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.

Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.

Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond.

pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy.

Related Experiment Videos

Hexamethylmelamine treatment of sarcomas and lymphomas

Related Concept Videos

Related Articles